Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study. (2022)
Attributed to:
University of Birmingham - Proximity to Discovery 2017
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-063199
PubMed Identifier: 36691123
Publication URI: http://europepmc.org/abstract/MED/36691123
Type: Journal Article/Review
Volume: 12
Parent Publication: BMJ open
Issue: 9
ISSN: 2044-6055